Please login to the form below

Not currently logged in
Email:
Password:

SMC

This page shows the latest SMC news and features for those working in and with pharma, biotech and healthcare.

Diurnal files adrenal insufficiency drug Alkindi in US

Diurnal files adrenal insufficiency drug Alkindi in US

It has since been backed by the Scottish Medicines Consortium (SMC) for reimbursement on the NHS.

Latest news

More from news
Approximately 15 fully matching, plus 86 partially matching documents found.

Latest Intelligence

  • The Orkambi row explained The Orkambi row explained

    December 2018: Scottish Government agrees a deal with Vertex pending submission of Orkambi and Symkevi to Scottish Medicines Consortium (SMC), with interim access possible through the PACS Tier 2 system.

  • The Orkambi blame game The Orkambi blame game

    Leiden also claimed the breakthrough in Scotland came when NICE’s equivalent, the SMC, agreed to ‘flex’ its methodology – something which he and other industry leaders said is vital if NICE

  • Patient involvement in health technology assessment Patient involvement in health technology assessment

    We have developed a Public Involvement Network (PIN) that formalises relationships with each submitting patient group through a registration process to become an SMC Patient Group Partner. ... SMC as a respected partner in developing and shaping all

  • The reality of real-world evidence The reality of real-world evidence

    Zaltrap re-submission to the Scottish Medicines Consortium (SMC) included RWE (pooled data from two open-label, single-arm studies) to demonstrate prolonged safety and QoL benefit.

  • Charting a course for expansion Charting a course for expansion

    The dossiers are going in and the conversations with NICE and the SMC are happening and we're cautiously optimistic.”.

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • Recent approval for your brand from NICE or SMC? Time to rethink your market access

    Scottish cost regulators have approved funding for five new therapies on the NHS, offering new treatment options for a range of conditions. Scottish cost regulators have approved funding for five new therapies on the NHS, offering new treatment

  • OUTiCO OUTiCO

    Recent approval for your brand from NICE or SMC? Time to rethink your market access.

  • YorkTown

    decision makers associated with pharmaceutical and medical device/diagnostics market access and HEOR; Developing and writing single technology appraisals (STA) (pharmaceutical and medical device) for regulatory institutions (NICE, EMA, SMC and

  • The Holistic Approach to Market Access

    and to provide local prescribing audit data for inclusion into NICE and SMC technical appraisals the gaining of which is a key element in gaining regional prescribing uptake.

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health is an integrated communications agency designed for and inspired by the ever-changing face of healthcare. In London, we...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics